U.S. Semiconductors Stock News

NYSE:PDM
NYSE:PDMOffice REITs

Piedmont Realty Trust (PDM) Q1 FFO Profile Tests Bullish Turnaround Narratives

Piedmont Realty Trust (PDM) opened 2026 with Q1 revenue of US$143.3 million and basic EPS of a US$0.10 loss, while trailing 12 month revenue was US$565.6 million and EPS was a US$0.69 loss. Over the past year, the company’s quarterly revenue moved from US$142.7 million in Q1 2025 to US$143.3 million in Q1 2026, with basic EPS shifting from a Q1 2025 loss of US$0.08 per share to a Q1 2026 loss of US$0.10 per share as investors consider how these margins may influence any potential...
NYSE:MHK
NYSE:MHKConsumer Durables

Mohawk Industries Q1 EPS Volatility Tests Bullish Margin Recovery Narratives

Mohawk Industries (MHK) opened 2026 with Q1 revenue of US$2.7 billion and basic EPS of US$1.91, setting the tone for how investors weigh the latest numbers against trailing profitability and growth expectations. Over the past few quarters, revenue has moved between US$2.5 billion in Q1 2025 and US$2.8 billion in Q2 2025, while basic EPS ranged from US$0.68 in Q4 2025 to US$2.35 in Q2 2025, providing a view of how earnings have tracked relative to a fairly steady top line. With trailing net...
NasdaqGS:LASR
NasdaqGS:LASRElectronic

nLIGHT Italy Expansion Deepens Ties To European Defense Laser Demand

nLIGHT (NasdaqGS:LASR) is expanding its operations in Torino, Italy to support rising regional demand for directed energy and high power laser solutions. The move is intended to serve European and allied customers with regionally tailored products and improve localization and supply chain resilience. This expansion marks a material step in nLIGHT's international build out and its focus on defense related laser technologies. For investors tracking nLIGHT, the expansion comes with the shares...
NasdaqCM:NXTT
NasdaqCM:NXTTSoftware

Next Technology Holding (NXTT) Posts US$105.9 Million Q1 Loss Reinforcing Bearish Narratives

Next Technology Holding (NasdaqCM:NXTT) opened 2026 with Q1 revenue of about US$0.5 million and a basic EPS loss of US$1.39 per share, alongside a net loss of US$105.9 million. Over recent quarters the company has seen revenue move from US$0 in Q1 2025 to US$9.8 million in Q4 2025 before landing at US$0.5 million in Q1 2026. EPS has swung from a very high profit of US$396.38 per share in Q1 2025 to a loss of US$1.39 in the latest quarter, setting a backdrop where reported margins look highly...
NYSE:BIPC
NYSE:BIPCGas Utilities

Brookfield Infrastructure Corp (BIPC) Q1 Loss Extends Earnings Concerns Despite Revenue Base

Brookfield Infrastructure (NYSE:BIPC) has opened 2026 with Q1 revenue of US$884 million and a basic EPS loss of US$0.93, setting the tone for another quarter where the income statement matters more than headline growth stories. Over the past year, quarterly revenue has ranged from US$866 million to US$956 million while EPS has swung between a gain of US$3.27 and a loss of US$4.01, highlighting how volatile profitability has been for shareholders watching margins. See our full analysis for...
NasdaqGS:BLKB
NasdaqGS:BLKBSoftware

Is It Time To Reassess Blackbaud (BLKB) After A Tough Year Of Share Price Losses

Wondering whether Blackbaud at around US$37.54 is a bargain or a value trap? This breakdown will help you size up what the current share price really reflects. The stock has been broadly flat over the last month at around 0.0%. However, that sits against a much tougher backdrop with a 36.9% decline year to date and a 38.9% decline over the past year. Those longer term returns mean many holders are sitting on losses, which often pushes valuation questions to the front of investors' minds...
NasdaqCM:PDEX
NasdaqCM:PDEXMedical Equipment

Pro Dex (PDEX) One Off Gain Inflated Earnings Challenges Bullish Narratives

Pro-Dex (PDEX) has put up a solid Q3 2026 print, with revenue of about US$19.9 million and basic EPS of roughly US$1.23, against a trailing twelve month backdrop where earnings grew 28.1% year over year and net profit margin sat at 16.1%. Over recent quarters the company has seen revenue move from around US$17.4 million in Q3 2025 to US$19.9 million in Q3 2026, while quarterly basic EPS ranged between roughly US$0.37 and US$1.43 over that stretch, giving a clear view of how revenue and per...
NYSE:AIG
NYSE:AIGInsurance

AIG (AIG) Net Margin Improvement In Q1 2026 Tests Persistent Risk Concerns

American International Group (AIG) opened 2026 with Q1 results that put the focus squarely on the income statement, as revenue came in at US$6.7b and basic EPS landed at US$1.42 on net income of US$763m. The company has seen revenue move from US$6.5b in Q1 2025 to US$6.7b in Q1 2026, while basic EPS over that stretch ranged from US$1.18 in Q1 2025 to US$1.42 in the latest quarter. This sets the stage for investors to weigh these headline figures against a backdrop of improving trailing net...
NasdaqCM:OSPN
NasdaqCM:OSPNSoftware

OneSpan (OSPN) Q1 EPS Stability Tests Bearish Earnings Decline Narrative

OneSpan (OSPN) Q1 2026 earnings snapshot OneSpan (OSPN) has opened 2026 with Q1 revenue of US$65.9 million and basic EPS of US$0.31, setting the tone for investors assessing how the business is converting its software demand into bottom line results. Over the past year, the company has seen trailing twelve month revenue sit at US$245.8 million with basic EPS of US$1.84, alongside earnings growth of 20.4% and net margins at 28.5% compared to 24% a year earlier. This provides useful context for...
NasdaqGS:LPLA
NasdaqGS:LPLACapital Markets

LPL Financial Holdings (LPLA) Q1 EPS Strength Tests Margin And Volatility Concerns

LPL Financial Holdings (LPLA) opened 2026 with Q1 revenue of about US$4.8b and basic EPS of US$4.45, as investors weigh these headline figures against a reported net margin of 5% over the trailing 12 months that was affected by a US$732.0m one off loss. The company has seen quarterly revenue move from US$3.4b in Q4 2024 to US$3.6b in Q1 2025 and then to about US$4.8b in Q1 2026. Over the last six reported periods, trailing 12 month basic EPS has ranged from US$14.17 to US$11.25, placing...
NasdaqCM:JBIO
NasdaqCM:JBIOBiotechs

Jade Biosciences Reshapes Clinical Leadership As Valuation Debate Persists

Jade Biosciences (NasdaqCM: JBIO) appointed Edward R. Conner, M.D. as Chief Medical Officer. The company elevated Andrew King, M.D., Ph.D. to President, Research & Development. These leadership changes focus on clinical development, regulatory strategy, and R&D continuity for Jade's autoimmune pipeline. Jade Biosciences, listed on NasdaqCM under the ticker JBIO, is focused on developing therapies for autoimmune conditions, an area that continues to attract capital and partnerships across...
NYSE:PBF
NYSE:PBFOil and Gas

PBF Energy (PBF) Q1 EPS Rebound Tests Bullish Margin Narratives

PBF Energy (PBF) opened 2026 with Q1 revenue of US$7.9b and basic EPS of US$1.69, alongside net income excluding extra items of US$198.3m, setting a clear marker after a volatile run of recent quarters. The company has seen quarterly revenue move from US$7.1b in Q1 2025 to US$7.9b in Q1 2026, while EPS shifted from a loss of US$3.53 in Q1 2025 to a profit of US$1.69 in the latest period. This points to a very different margin profile as investors gauge how durable this reset may be. See our...
NYSE:DAL
NYSE:DALAirlines

Is It Time To Reassess Delta Air Lines (DAL) After Its 58% One Year Rally?

Wondering whether Delta Air Lines at around US$68.98 is offering good value or stretching expectations? This article will help you size up the stock through a clear valuation lens. The share price has moved by 0.8% over the last 7 days and 2.0% over the last 30 days, with a 1 year return of 58.0% and a 3 year return of 109.5%, while the year to date figure sits at a slight 0.1% decline. Recent headlines have focused on Delta Air Lines in the context of broader airline sector themes,...
NasdaqGS:AUR
NasdaqGS:AURSoftware

Is It Time To Reconsider Aurora Innovation (AUR) After Its Recent Share Price Surge?

Investors may be wondering whether Aurora Innovation's share price reflects its true worth, or if the market is mispricing the story right now. The stock recently closed at US$6.13, with returns of 24.8% over 7 days, 46.7% over 30 days, 58.4% year to date, and a 24.7% decline over the past year, alongside a very large gain over 3 years. Recent coverage has focused on how autonomous driving and AI related names are being reassessed by investors, as attention shifts to companies tied to real...
NasdaqCM:CORT
NasdaqCM:CORTPharmaceuticals

Is Corcept Therapeutics (CORT) Pricing Make Sense After Recent Volatility In The Share Price

If you are wondering whether Corcept Therapeutics at around US$51.42 is attractively priced or already stretched, starting with a clear view of valuation can help frame your next move. The stock has seen sharp swings recently, with returns of 11.6% over 7 days, 22.5% over 30 days, 34.6% year to date, but a 29.3% decline over the past year and gains of 113.6% over 3 years and 143.7% over 5 years. Recent coverage has focused on how this price history shapes expectations for Corcept...
NYSE:TRV
NYSE:TRVInsurance

Is Travelers Companies (TRV) Pricing Reflecting Its Recent Share Gains And Earnings Valuation?

For investors considering whether Travelers Companies at around US$304.72 represents fair value or whether the price may be ahead of itself, this article examines what the available numbers indicate about the stock. The share price has moved by 0.7% over the past week, 4.9% over the last month, 6.8% year to date and 15.8% over the past year. These figures provide useful context before assessing the underlying value. Recent news coverage has focused on Travelers Companies as a major U.S...
NasdaqGS:CARG
NasdaqGS:CARGInteractive Media and Services

A Look At CarGurus (CARG) Valuation As Shares Trade Near Analyst Fair Value Estimates

Why CarGurus Stock Is on Investors’ Radar CarGurus (CARG) has drawn investor interest after recent trading left the shares around US$37.04, with returns over the past month and past 3 months outpacing its year to date performance. See our latest analysis for CarGurus. That recent move to US$37.04 follows a 10.4% 30 day share price return and a 14.3% 90 day share price return, set against a year to date share price return that is slightly negative and a 31.4% 1 year total shareholder return...
NYSE:NIO
NYSE:NIOAuto

Assessing Nio (NIO) Valuation After Strong Deliveries Onvo L80 Launch And 900V Tech Partnership

NIO (NIO) is back in focus after April deliveries reached 29,356 vehicles and the All New ES8 crossed 100,000 cumulative units, alongside expanded 900V technology collaboration with Onsemi and the Onvo L80 rollout. See our latest analysis for NIO. Despite the recent 1 day share price return of a 7.51% decline to $5.91 and a 7 day share price return of a 4.83% decline, NIO has a 90 day share price return of 25.74% and a 1 year total shareholder return of 46.65%, although the 5 year total...
NYSE:OHI
NYSE:OHIHealth Care REITs

Omega Healthcare Investors (OHI) Q1 FFO Highlights Tenant Risk Narrative Tension

Omega Healthcare Investors (OHI) opened 2026 with Q1 revenue of US$323 million and basic EPS of US$0.47, alongside funds from operations of US$249 million and FFO per share of US$0.84, setting a clear snapshot of cash generation and earnings at the start of the year. Over the past reported quarters, revenue has moved from US$277 million in Q1 2025 to US$319 million in Q4 2025 and EPS has ranged between US$0.34 and US$0.60 over that period. This gives investors a recent history of how the top...
NYSE:AHR
NYSE:AHRHealth Care REITs

Is It Too Late To Consider American Healthcare REIT (AHR) After 58% One-Year Rally?

Wondering if American Healthcare REIT is reasonably priced at around US$50 a share, or if the market is getting ahead of itself? This article walks through what the current numbers actually say about value. The stock recently closed at US$50.15, with returns of 0.1% over 7 days, 5.5% over 30 days, 6.2% year to date and 57.7% over the past year. This naturally raises questions about how much of the story is already reflected in the price. Recent coverage has focused on American Healthcare...
NasdaqGS:ALGN
NasdaqGS:ALGNMedical Equipment

Align Technology (ALGN) Margin Resilience Reinforces Bullish Narratives After Q1 2026 Earnings

Align Technology (ALGN) opened 2026 with Q1 revenue of about US$1.0 billion and basic EPS of US$1.58, setting the tone for how investors will read the rest of the year. The company has seen quarterly revenue move from US$979.3 million in Q1 2025 through US$995.2 million in Q4 2024 to just over US$1.0 billion in the latest quarter, while basic EPS over the same span ranged from US$1.27 in Q1 2025 to US$1.89 in Q4 2025 before landing at US$1.58 in Q1 2026. This provides a clear run-rate on both...
NasdaqGS:VEON
NasdaqGS:VEONWireless Telecom

Assessing VEON (NasdaqGS:VEON) Valuation After Kyivstar’s Accelerated Ukraine Investment Program

Why Kyivstar’s Ukraine investment program matters for VEON (NasdaqGS:VEON) VEON (NasdaqGS:VEON) is back in focus after Kyivstar completed a multi year, US$1.3b investment program in Ukraine ahead of schedule, surpassing the group’s original 2023 to 2027 commitment by 30%. See our latest analysis for VEON. VEON’s latest Ukraine update comes as the share price trades at US$49.74, with a 7.43% 1 month share price return but a 5.62% decline year to date. The 3 year total shareholder return of...
NasdaqGS:ORLY
NasdaqGS:ORLYSpecialty Retail

O'Reilly Automotive (ORLY) Earnings Growth Outpaces Five Year Trend Reinforcing Bullish Margin Narrative

O'Reilly Automotive (ORLY) opened 2026 with Q1 revenue of US$4.6b and basic EPS of US$0.72, supported by trailing twelve month revenue of US$18.2b and EPS of US$3.08 that point to earnings growth of 9.5% over the past year. Over the last five reported quarters, the company has seen revenue move from US$4.1b in Q1 2025 to US$4.6b in Q1 2026, while quarterly EPS ranged between US$0.63 and US$0.86 across that period as trailing net income reached US$2.6b. With net profit margins running at...
NasdaqGS:STNE
NasdaqGS:STNEDiversified Financial

Is StoneCo (STNE) Now An Opportunity After Recent Share Price Slide?

This article examines whether StoneCo, trading at around US$10.98, could be considered a bargain or a value trap by focusing on what the current share price might imply about the company. The stock has experienced significant recent volatility, with a 24.5% decline over the last week, a 22.2% decline over the last month, and a 25.3% decline year to date. Over longer periods, the 1 year return shows a 4.3% decline and the 5 year return a 78.3% decline. Recent commentary around StoneCo has...